Nabilone is contraindicated in individuals with a history of hypersensitivity to cannabinoids. It should also be used cautiously in patients with a history of psychiatric disorders, such as depression or schizophrenia, due to the risk of exacerbating these conditions. Pregnant or breastfeeding women should avoid nabilone unless the potential benefits outweigh the risks, as its safety in these populations has not been firmly established.
